RxDoctor Payments Data

Preston Sprenkle, MD

Urology · New Haven, CTNPI 1871750190

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boston Scientific at 42.0% of the total. Among urology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,356in general payments, 2019–2025

Across 114 payments — averaging $503.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$24K
  • Profound Medical Corp.$11K
  • Telix Pharmaceuticals$7K
  • Intuitive Surgical$5K
  • Blue Earth Diagnostics$3K
  • Progenics Pharmaceuticals, Inc.$2K
  • plus $5K from 12 others

What the payments were for

  • Consulting fees$20,91336%
  • Speaking & faculty fees$12,91323%
  • Travel & lodging$17,30430%
  • Food & beverage$6,14911%
  • Entertainment$790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,356 in reported general payments places this provider in the 95th percentile of 156 urology providers in Connecticut.

See all urology providers in Connecticut

Medicare billing

Part B allowed, 2024
$47,751
Medicare patients
130
Services billed
367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl42$575

Paid to pharmacies, not to this prescriber.

Other urology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →